---
title: "Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension"
canonical: "https://www.renown.org/clinical-trials-directory/NCT06911632"
last_updated: "2026-07-22T16:34:15Z"
---

# Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

URL: https://www.renown.org/clinical-trials-directory/NCT06911632

Short Title: Momentous

Enrollment Status: Recruiting

NCT #: [NCT06911632](https://clinicaltrials.gov/study/NCT06911632)

Specialty Area: Pulmonology

Condition Studied: Interstitial Lung Disease (ILD) with Pulmonary Hypertension (PH)

Age Groups: Adult; Older Adult

Sex: All

Study Type: Observational

Accepts Healthy Volunteers: No

Phase: Not Applicable

Principal Investigator: Farah Madhani-Lovely, MD

Complete Study Details: https://clinicaltrials.gov/study/NCT06911632

## Study Information

### Summary / Purpose

The goal of this study is to evaluate the use of an electrocardiogram (ECG)-based AI device that may help predict if participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension (PH).

### Who Can Participate

- Adults 18+ years of age
- Diagnosed with interstitial lung disease

### What's Involved

- Electrocardiogram (ECG), analyzed using an artificial intelligence (AI) tool designed to identify people who may be at higher risk for undiagnosed pulmonary hypertension
- Pulmonary function test
- Computed Tomography (CT) Imaging
- Blood sample

If identified as being at higher risk, undergo additional heart and lung evaluations, which may include:

- Echocardiogram (heart ultrasound)
- Right heart catheterization, a procedure used to assess heart function and measure pressures in the right side of the heart and pulmonary artery

## Additional Information

Location: Renown Health, Office of Clinical Research

Address: 1500 E 2nd St. Reno, NV 89502

General Research: [775-982-3646](tel:775-982-3646)

Oncology Research: [775-982-5050](tel:775-982-5050)

Email: [Renown-CRD@renown.org](mailto:Renown-CRD@renown.org)
